 Carolyn Decker
Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Double-Stranded | 2 | 2019 | 47 | 1.080 |
Why?
| | RNA Viruses | 2 | 2019 | 34 | 1.070 |
Why?
| | Cytoplasmic Granules | 2 | 2022 | 78 | 0.860 |
Why?
| | Ribonucleoproteins | 4 | 2022 | 87 | 0.790 |
Why?
| | RNA Virus Infections | 1 | 2019 | 13 | 0.650 |
Why?
| | RNA | 4 | 2023 | 882 | 0.560 |
Why?
| | Saccharomyces cerevisiae | 5 | 2024 | 530 | 0.560 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 487 | 0.510 |
Why?
| | RNA, Viral | 3 | 2021 | 620 | 0.500 |
Why?
| | RNA, Messenger | 3 | 2023 | 2708 | 0.480 |
Why?
| | RNA Stability | 3 | 2012 | 103 | 0.450 |
Why?
| | Protein Biosynthesis | 3 | 2024 | 410 | 0.440 |
Why?
| | Saliva | 3 | 2023 | 211 | 0.390 |
Why?
| | Carrier State | 2 | 2021 | 60 | 0.350 |
Why?
| | Models, Genetic | 1 | 2012 | 593 | 0.320 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2007 | 383 | 0.300 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2007 | 11 | 0.290 |
Why?
| | Asparagine | 1 | 2007 | 30 | 0.280 |
Why?
| | Glutamine | 1 | 2007 | 100 | 0.270 |
Why?
| | RNA-Binding Proteins | 3 | 2006 | 387 | 0.250 |
Why?
| | Drosophila Proteins | 1 | 2006 | 185 | 0.220 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2006 | 194 | 0.210 |
Why?
| | Endoplasmic Reticulum | 1 | 2006 | 261 | 0.210 |
Why?
| | Virion | 2 | 2021 | 83 | 0.200 |
Why?
| | Iron | 1 | 2024 | 282 | 0.190 |
Why?
| | Vero Cells | 1 | 2019 | 66 | 0.160 |
Why?
| | Cell Nucleus | 1 | 2022 | 584 | 0.150 |
Why?
| | Genome, Viral | 1 | 2019 | 128 | 0.150 |
Why?
| | Cell Membrane | 1 | 2022 | 734 | 0.150 |
Why?
| | Virus Replication | 1 | 2019 | 452 | 0.130 |
Why?
| | Schizosaccharomyces pombe Proteins | 2 | 2008 | 49 | 0.130 |
Why?
| | Protein Structure, Tertiary | 5 | 2008 | 843 | 0.110 |
Why?
| | Contig Mapping | 1 | 2014 | 10 | 0.110 |
Why?
| | Water Microbiology | 1 | 2014 | 82 | 0.110 |
Why?
| | Endoribonucleases | 2 | 2004 | 72 | 0.100 |
Why?
| | Metagenomics | 1 | 2014 | 156 | 0.100 |
Why?
| | Base Sequence | 2 | 2014 | 2147 | 0.100 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2012 | 42 | 0.100 |
Why?
| | Crystallography, X-Ray | 4 | 2008 | 438 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 398 | 0.100 |
Why?
| | Blotting, Western | 1 | 2014 | 1206 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1035 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 778 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2542 | 0.080 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2008 | 22 | 0.080 |
Why?
| | Models, Biological | 2 | 2007 | 1724 | 0.070 |
Why?
| | Two-Hybrid System Techniques | 1 | 2007 | 56 | 0.070 |
Why?
| | RNA Caps | 2 | 2004 | 33 | 0.070 |
Why?
| | Cytoplasm | 1 | 2007 | 269 | 0.070 |
Why?
| | Oligonucleotides | 1 | 2007 | 143 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2008 | 215 | 0.070 |
Why?
| | Animals | 4 | 2024 | 35391 | 0.060 |
Why?
| | Schizosaccharomyces | 1 | 2005 | 58 | 0.060 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2024 | 26 | 0.060 |
Why?
| | Mice | 1 | 2019 | 16961 | 0.050 |
Why?
| | Mammals | 1 | 2024 | 275 | 0.050 |
Why?
| | Models, Molecular | 4 | 2008 | 1491 | 0.050 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 26 | 0.050 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 32 | 0.050 |
Why?
| | Acute Disease | 1 | 2023 | 979 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 98 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 162 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1713 | 0.040 |
Why?
| | Viral Load | 1 | 2021 | 449 | 0.040 |
Why?
| | Amino Acid Sequence | 3 | 2008 | 2057 | 0.040 |
Why?
| | Universities | 1 | 2021 | 409 | 0.040 |
Why?
| | Structural Homology, Protein | 2 | 2008 | 25 | 0.030 |
Why?
| | Protein Structure, Quaternary | 2 | 2008 | 122 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1843 | 0.030 |
Why?
| | Humans | 6 | 2024 | 129625 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2835 | 0.030 |
Why?
| | Mass Screening | 1 | 2021 | 1190 | 0.030 |
Why?
| | Binding Sites | 2 | 2008 | 1248 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3968 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2057 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4404 | 0.020 |
Why?
| | Protein Binding | 2 | 2008 | 2124 | 0.020 |
Why?
| | Dimerization | 1 | 2008 | 192 | 0.020 |
Why?
| | Glutathione Transferase | 1 | 2008 | 102 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 332 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 361 | 0.020 |
Why?
| | Alanine | 1 | 2008 | 142 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 341 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 283 | 0.020 |
Why?
| | Pyrophosphatases | 1 | 2005 | 22 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 479 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 651 | 0.010 |
Why?
| | Catalysis | 1 | 2005 | 310 | 0.010 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2004 | 4 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2004 | 227 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 183 | 0.010 |
Why?
| | Pheromones | 1 | 2003 | 29 | 0.010 |
Why?
| | Glycerol | 1 | 2003 | 92 | 0.010 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2003 | 68 | 0.010 |
Why?
| | Fungal Proteins | 1 | 2003 | 130 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2003 | 1087 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 1002 | 0.010 |
Why?
| | Mutation | 1 | 2004 | 3717 | 0.010 |
Why?
|
|
Decker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|